CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- 6-K Event Report of Foreign Issuer
- SC 13D/A Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- CT ORDER Other Confidential Order
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- UPLOAD Other SEC-generated Letter
- F-6 Other Registration of American Depositary Receipt Shares
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- UPLOAD Other SEC-generated Letter
- F-1 Offering Registration Statement for Certain Foreign Private Issuers
- UPLOAD Other SEC-generated Letter
Page 28 of 29 · 564 filings